Anygen Co., Ltd.
Records under this name other than the patents Anygen Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 5 of 5 · Back to Anygen Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,859,783 | INDIRUBIN-3'-Oxime Derivatives as Potent Cyclin Dependent Kinase Inhibitors Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 7,572,923 | Indirubin derivatives having anticancer property against human cancer cell line Term ended Term ended May 2, 2025 · From the USPTO record | Term ended | Term ended May 2, 2025 | From the USPTO record |
| US 8,673,856 | Omega conotoxins Lapsed on the fee record Ended Mar 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2022 | From the USPTO record |
| US 9,556,242 | Method for Regulating Circadian Rhythms Lapsed on the fee record Ended Jan 31, 2021 · High confidence | Lapsed on the fee record | Ended Jan 31, 2021 | High confidence |
| US 7,812,177 | Potassium channel opener having benzofuroindole skeleton Lapsed on the fee record Ended Oct 12, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 12, 2018 | From the USPTO record |